Broad Institute Launches Center to Standardise Rare Disease Gene Therapy

References

1. 1.Chiu, A. (2026, July 21). Broad Institute, partners unveil new initiative to develop gene therapies for rare diseases. STAT News. https://www.statnews.com/2026/07/21/center-for-therapeutic-genetics-rare-disease-gene-therapies/
2. 2.Nguengang Wakap, S., Lambert, D. M., Olry, A., Rodwell, C., Gueydan, C., Lanneau, V., Murphy, D., Le Cam, Y., & Rath, A. (2020). Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. European Journal of Human Genetics, 28(2), 165–173. https://doi.org/10.1038/s41431-019-0508-0
3. 3.Marks, P., & Gottlieb, S. (2021). Balancing safety and innovation for cell and gene therapies. New England Journal of Medicine, 384(2), 98–101. https://doi.org/10.1056/NEJMp2031338
4. 4.Philippidis, A. (2024). Gene therapy's cost conundrum: Can platform approaches reduce the price of rare disease treatments? Human Gene Therapy, 35(1), 1–4. https://doi.org/10.1089/hum.2024.29252.bfs
5. 5.Therapeutic Goods Administration. (2023). Regulation of biologicals in Australia: Guidance for sponsors and manufacturers. Australian Government Department of Health and Aged Care. https://www.tga.gov.au/resources/publication/publications/regulation-biologicals-australia
6. 6.Stark, Z., Dolman, L., Manolio, T. A., Ozenberger, B., Hill, S. L., Caulfield, M. J., Levy, Y., Glazer, D., Wilson, J., Lawler, M., Boughtwood, T., Braithwaite, J., Goodhand, P., Birney, E., & North, K. N. (2019). Integrating genomics into healthcare: A global responsibility. American Journal of Human Genetics, 104(4), 554–558. https://doi.org/10.1016/j.ajhg.2019.02.013
7. 7.High, K. A., & Roncarolo, M. G. (2019). Gene therapy. New England Journal of Medicine, 381(5), 455–464. https://doi.org/10.1056/NEJMra1706910
8. 8.Dunbar, C. E., High, K. A., Joung, J. K., Kohn, D. B., Ozawa, K., & Sadelain, M. (2018). Gene therapy comes of age. Science, 359(6372), eaan4672. https://doi.org/10.1126/science.aan4672